Clinical trial
Peginterferon Alfa-2a Plus Ribavirin for Chronic Hepatitis C/Hepatitis B…
NCT00154869 · National Taiwan University Hospital, Other · Unknown status
Key facts
| NCT number | NCT00154869 |
|---|---|
| Title | Peginterferon Alfa-2a Plus Ribavirin for Chronic Hepatitis C/Hepatitis B Co-Infection and Chronic Hepatitis C |
| Official title | An Open Label, Comparative, Multi-Center Study, to Evaluate the Efficacy and Safety of Peginterferon Alfa-2a Plus Ribavirin in the Treatment of Patients With Chronic Hepatitis C/Hepatitis B Co-Infection and Chronic Hepatitis C |
| Lead sponsor | National Taiwan University Hospital, Other |
| Collaborators | Hoffmann-La Roche Industry |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hepatitis B, Chronic, Hepatitis C |
| Intervention type | Drug |
| Interventions | Peginterferon Alfa-2a plus Ribavirin |
| Enrollment | 320 |
| Start date | Jun 1, 2004 |
| Completion | Aug 1, 2007 |
| First posted | Sep 12, 2005 |
| Last update posted | Aug 13, 2007 |
| Countries | Taiwan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: